_id
691301a0ccc777a4e85d7941
Ticker
INAB
Name
In8bio Inc
Exchange
NASDAQ
Address
350 5th Avenue, New York, NY, United States, 10118
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://in8bio.com
Description
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Last Close
1.73
Volume
19420
Current Price
1.68
Change
-2.890173410404627
Last Updated
2025-12-01T09:19:42.051Z
Image
data:image/webp;base64,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
Ipo Date
2021-07-30T00:00:00.000Z
Market Cap
9176104
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0
Sentiment Sources
1
Rating
4.5
Target Price
46.9
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
3854000
Operating Income
-3854000
Interest Expense
-
Pretax Income
-3854000
Net Income
-3854000
Eps
-0.8493321371281335
Dividends Per Share
-
Shares Outstanding
4634396
Income Tax Expense
-
EBITDA
-3327000
Operating Margin
-
Total Other Income Expense Net
-
Cash
10689000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
11768000
Property Plant Equipment
4558000
Total Assets
16768000
Payables
204000
Short Term Debt
1081000
Long Term Debt
-
Total Liabilities
3579000
Equity
13189000
Depreciation
401000
Change In Working Capital
-889000
Cash From Operations
-3524000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
989000
Net Change In Cash
-2537000
PE
-
PB
0.5780049617105163
ROE
-29.22132079763439
ROA
-22.984255725190838
FCF
-3524000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
3854000
Quarters > 0 > income Statement > operating Income
-3854000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3854000
Quarters > 0 > income Statement > net Income
-3854000
Quarters > 0 > income Statement > eps
-0.8493321371281335
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4537683
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3327000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > balance Sheet > cash
10689000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11768000
Quarters > 0 > balance Sheet > property Plant Equipment
4558000
Quarters > 0 > balance Sheet > total Assets
16768000
Quarters > 0 > balance Sheet > payables
204000
Quarters > 0 > balance Sheet > short Term Debt
1081000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
3579000
Quarters > 0 > balance Sheet > equity
13189000
Quarters > 0 > cash Flow > net Income
-3854000
Quarters > 0 > cash Flow > depreciation
401000
Quarters > 0 > cash Flow > change In Working Capital
-889000
Quarters > 0 > cash Flow > cash From Operations
-3524000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
989000
Quarters > 0 > cash Flow > net Change In Cash
-2537000
Quarters > 0 > ratios > PE
-0.8493321371281335
Quarters > 0 > ratios > PB
0.5780049617105163
Quarters > 0 > ratios > ROE
-29.22132079763439
Quarters > 0 > ratios > ROA
-22.984255725190838
Quarters > 0 > ratios > FCF
-3524000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
498000
Quarters > 1 > income Statement > gross Profit
-498000
Quarters > 1 > income Statement > operating Expenses
5094000
Quarters > 1 > income Statement > operating Income
-5094000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5094000
Quarters > 1 > income Statement > net Income
-5094000
Quarters > 1 > income Statement > eps
-1.236662003086557
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4119153
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4417000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
107000
Quarters > 1 > balance Sheet > cash
13226000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
13741000
Quarters > 1 > balance Sheet > property Plant Equipment
5084000
Quarters > 1 > balance Sheet > total Assets
19371000
Quarters > 1 > balance Sheet > payables
379000
Quarters > 1 > balance Sheet > short Term Debt
940000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4132000
Quarters > 1 > balance Sheet > equity
15239000
Quarters > 1 > cash Flow > net Income
-5094000
Quarters > 1 > cash Flow > depreciation
541000
Quarters > 1 > cash Flow > change In Working Capital
-572000
Quarters > 1 > cash Flow > cash From Operations
-3927000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
5267000
Quarters > 1 > cash Flow > net Change In Cash
1340000
Quarters > 1 > ratios > PE
-1.236662003086557
Quarters > 1 > ratios > PB
0.45410965548920534
Quarters > 1 > ratios > ROE
-33.42739024870398
Quarters > 1 > ratios > ROA
-26.29704196995509
Quarters > 1 > ratios > FCF
-3927000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
429000
Quarters > 2 > income Statement > gross Profit
-429000
Quarters > 2 > income Statement > operating Expenses
5550000
Quarters > 2 > income Statement > operating Income
-5550000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-5550000
Quarters > 2 > income Statement > net Income
-5550000
Quarters > 2 > income Statement > eps
-0.06648129764305832
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
83482125
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4991000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
110000
Quarters > 2 > balance Sheet > cash
11888000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
12725000
Quarters > 2 > balance Sheet > property Plant Equipment
6600000
Quarters > 2 > balance Sheet > total Assets
19869000
Quarters > 2 > balance Sheet > payables
575000
Quarters > 2 > balance Sheet > short Term Debt
1237000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
5992000
Quarters > 2 > balance Sheet > equity
13877000
Quarters > 2 > cash Flow > net Income
-5550000
Quarters > 2 > cash Flow > depreciation
669000
Quarters > 2 > cash Flow > change In Working Capital
928000
Quarters > 2 > cash Flow > cash From Operations
-3122000
Quarters > 2 > cash Flow > capital Expenditures
33000
Quarters > 2 > cash Flow > cash From Investing
-33000
Quarters > 2 > cash Flow > cash From Financing
3893000
Quarters > 2 > cash Flow > net Change In Cash
771000
Quarters > 2 > ratios > PE
-0.06648129764305832
Quarters > 2 > ratios > PB
10.106649131656697
Quarters > 2 > ratios > ROE
-39.994235065215825
Quarters > 2 > ratios > ROA
-27.932960893854748
Quarters > 2 > ratios > FCF
-3155000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2526000
Quarters > 3 > income Statement > cost Of Revenue
1263000
Quarters > 3 > income Statement > gross Profit
-702000
Quarters > 3 > income Statement > operating Expenses
6160000
Quarters > 3 > income Statement > operating Income
-6160000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-6160000
Quarters > 3 > income Statement > net Income
-6160000
Quarters > 3 > income Statement > eps
-0.10869265445689377
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
56673563
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5522000
Quarters > 3 > income Statement > operating Margin
-243.86381631037213
Quarters > 3 > income Statement > total Other Income Expense Net
64000
Quarters > 3 > balance Sheet > cash
11120000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
12578000
Quarters > 3 > balance Sheet > property Plant Equipment
7825000
Quarters > 3 > balance Sheet > total Assets
20944000
Quarters > 3 > balance Sheet > payables
389000
Quarters > 3 > balance Sheet > short Term Debt
1647000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6466000
Quarters > 3 > balance Sheet > equity
14478000
Quarters > 3 > cash Flow > net Income
-6160000
Quarters > 3 > cash Flow > depreciation
702000
Quarters > 3 > cash Flow > change In Working Capital
605000
Quarters > 3 > cash Flow > cash From Operations
-4027999
Quarters > 3 > cash Flow > capital Expenditures
33000
Quarters > 3 > cash Flow > cash From Investing
-33000
Quarters > 3 > cash Flow > cash From Financing
11187000
Quarters > 3 > cash Flow > net Change In Cash
7119000
Quarters > 3 > ratios > PE
-0.10869265445689377
Quarters > 3 > ratios > PB
6.5762940903439695
Quarters > 3 > ratios > ROE
-42.54731316480177
Quarters > 3 > ratios > ROA
-29.411764705882355
Quarters > 3 > ratios > FCF
-4060999
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.6076797307996833
Quarters > 3 > health Score
27
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2655000
Annuals > 0 > income Statement > gross Profit
-2655000
Annuals > 0 > income Statement > operating Expenses
30437000
Annuals > 0 > income Statement > operating Income
-30437000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-30437000
Annuals > 0 > income Statement > net Income
-30437000
Annuals > 0 > income Statement > eps
-0.568416212813297
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
53547030
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-26944000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-838000
Annuals > 0 > balance Sheet > cash
11120000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
12578000
Annuals > 0 > balance Sheet > property Plant Equipment
7825000
Annuals > 0 > balance Sheet > total Assets
20944000
Annuals > 0 > balance Sheet > payables
389000
Annuals > 0 > balance Sheet > short Term Debt
1647000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6466000
Annuals > 0 > balance Sheet > equity
14478000
Annuals > 0 > cash Flow > net Income
-30437000
Annuals > 0 > cash Flow > depreciation
2655000
Annuals > 0 > cash Flow > change In Working Capital
-1412000
Annuals > 0 > cash Flow > cash From Operations
-24149000
Annuals > 0 > cash Flow > capital Expenditures
104000
Annuals > 0 > cash Flow > cash From Investing
-187000
Annuals > 0 > cash Flow > cash From Financing
14184000
Annuals > 0 > cash Flow > net Change In Cash
-10152000
Annuals > 0 > ratios > PE
-0.568416212813297
Annuals > 0 > ratios > PB
7.32305010360547
Annuals > 0 > ratios > ROE
-210.22931344108304
Annuals > 0 > ratios > ROA
-145.32563025210084
Annuals > 0 > ratios > FCF
-24253000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
2501000
Annuals > 1 > income Statement > gross Profit
-2501000
Annuals > 1 > income Statement > operating Expenses
27836000
Annuals > 1 > income Statement > operating Income
-30337000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-30007000
Annuals > 1 > income Statement > net Income
-30007000
Annuals > 1 > income Statement > eps
-1.0047547296166082
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
29865000
Annuals > 1 > income Statement > income Tax Expense
-32838000
Annuals > 1 > income Statement > EBITDA
-27506000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
330000
Annuals > 1 > balance Sheet > cash
21282000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
24625000
Annuals > 1 > balance Sheet > property Plant Equipment
8573000
Annuals > 1 > balance Sheet > total Assets
33709000
Annuals > 1 > balance Sheet > payables
924000
Annuals > 1 > balance Sheet > short Term Debt
1514000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
8772000
Annuals > 1 > balance Sheet > equity
24937000
Annuals > 1 > cash Flow > net Income
-30007000
Annuals > 1 > cash Flow > depreciation
2501000
Annuals > 1 > cash Flow > change In Working Capital
-204000
Annuals > 1 > cash Flow > cash From Operations
-23340000
Annuals > 1 > cash Flow > capital Expenditures
600000
Annuals > 1 > cash Flow > cash From Investing
-600000
Annuals > 1 > cash Flow > cash From Financing
27044000
Annuals > 1 > cash Flow > net Change In Cash
3100000
Annuals > 1 > ratios > PE
-1.0047547296166082
Annuals > 1 > ratios > PB
2.3712836347595942
Annuals > 1 > ratios > ROE
-120.33123471147292
Annuals > 1 > ratios > ROA
-89.01776973508558
Annuals > 1 > ratios > FCF
-23940000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1103000
Annuals > 2 > income Statement > gross Profit
-1103000
Annuals > 2 > income Statement > operating Expenses
28521000
Annuals > 2 > income Statement > operating Income
-28521000
Annuals > 2 > income Statement > interest Expense
1103000
Annuals > 2 > income Statement > pretax Income
-28521000
Annuals > 2 > income Statement > net Income
-27418000
Annuals > 2 > income Statement > eps
-1.3076115986264785
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
20968000
Annuals > 2 > income Statement > income Tax Expense
-1103000
Annuals > 2 > income Statement > EBITDA
-27418000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > balance Sheet > cash
18182000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
22234000
Annuals > 2 > balance Sheet > property Plant Equipment
10298000
Annuals > 2 > balance Sheet > total Assets
33039000
Annuals > 2 > balance Sheet > payables
2091000
Annuals > 2 > balance Sheet > short Term Debt
1389000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
10307000
Annuals > 2 > balance Sheet > equity
22732000
Annuals > 2 > cash Flow > net Income
-28521000
Annuals > 2 > cash Flow > depreciation
1103000
Annuals > 2 > cash Flow > change In Working Capital
-170000
Annuals > 2 > cash Flow > cash From Operations
-24121000
Annuals > 2 > cash Flow > capital Expenditures
3705000
Annuals > 2 > cash Flow > cash From Investing
-3705000
Annuals > 2 > cash Flow > cash From Financing
8988000
Annuals > 2 > cash Flow > net Change In Cash
-18838000
Annuals > 2 > ratios > PE
-1.3076115986264785
Annuals > 2 > ratios > PB
1.826352278726025
Annuals > 2 > ratios > ROE
-120.61411226464895
Annuals > 2 > ratios > ROA
-82.98677320742152
Annuals > 2 > ratios > FCF
-27826000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
251000
Annuals > 3 > income Statement > gross Profit
-251000
Annuals > 3 > income Statement > operating Expenses
14653000
Annuals > 3 > income Statement > operating Income
-14653000
Annuals > 3 > income Statement > interest Expense
788000
Annuals > 3 > income Statement > pretax Income
-14653000
Annuals > 3 > income Statement > net Income
-14653000
Annuals > 3 > income Statement > eps
-0.780193343975867
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
18781242
Annuals > 3 > income Statement > income Tax Expense
551442
Annuals > 3 > income Statement > EBITDA
-13865000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > balance Sheet > cash
37021000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
38980000
Annuals > 3 > balance Sheet > property Plant Equipment
2834000
Annuals > 3 > balance Sheet > total Assets
42223000
Annuals > 3 > balance Sheet > payables
395000
Annuals > 3 > balance Sheet > short Term Debt
626000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
4040000
Annuals > 3 > balance Sheet > equity
38183000
Annuals > 3 > cash Flow > net Income
-14653000
Annuals > 3 > cash Flow > depreciation
788000
Annuals > 3 > cash Flow > change In Working Capital
-1839000
Annuals > 3 > cash Flow > cash From Operations
-13509000
Annuals > 3 > cash Flow > capital Expenditures
309000
Annuals > 3 > cash Flow > cash From Investing
-309000
Annuals > 3 > cash Flow > cash From Financing
32955000
Annuals > 3 > cash Flow > net Change In Cash
19137000
Annuals > 3 > ratios > PE
-0.780193343975867
Annuals > 3 > ratios > PB
0.9739114045517638
Annuals > 3 > ratios > ROE
-38.37571694209465
Annuals > 3 > ratios > ROA
-34.70383440305047
Annuals > 3 > ratios > FCF
-13818000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.8493321371281335
Valuation > metrics > PB
0.5780049617105163
Valuation > final Score
70
Valuation > verdict
42.2% Undervalued
Profitability > metrics > ROE
-29.22132079763439
Profitability > metrics > ROA
-32.74983004758668
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2713624990522405
Risk > metrics > Interest Coverage
-7.313092979127135
Risk > final Score
31
Risk > verdict
High
Liquidity > metrics > Current Ratio
9.157976653696497
Liquidity > metrics > Quick Ratio
9.157976653696497
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
30
Prev Risks > 1
20
Prev Risks > 2
21
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T00:40:18.548Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.85
Earnings History > 0 > eps Estimate
-0.05
Earnings History > 0 > eps Difference
-0.8
Earnings History > 0 > surprise Percent
-1600
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.24
Earnings History > 1 > eps Estimate
-0.06
Earnings History > 1 > eps Difference
-1.18
Earnings History > 1 > surprise Percent
-1966.6667
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-2.1
Earnings History > 2 > eps Estimate
-0.0725
Earnings History > 2 > eps Difference
-2.0275
Earnings History > 2 > surprise Percent
-2796.5517
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-13
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.08
Earnings History > 3 > eps Estimate
-0.07
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-14.2857
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.15
Earnings History > 4 > eps Estimate
-0.17
Earnings History > 4 > eps Difference
0.02
Earnings History > 4 > surprise Percent
11.7647
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.19
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-11.7647
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2
Earnings History > 6 > eps Estimate
-0.18
Earnings History > 6 > eps Difference
-0.02
Earnings History > 6 > surprise Percent
-11.1111
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.21
Earnings History > 7 > eps Estimate
-0.15
Earnings History > 7 > eps Difference
-0.06
Earnings History > 7 > surprise Percent
-40
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.23
Earnings History > 8 > eps Estimate
-0.24
Earnings History > 8 > eps Difference
0.01
Earnings History > 8 > surprise Percent
4.1667
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.27
Earnings History > 9 > eps Estimate
-0.27
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-12
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.3
Earnings History > 10 > eps Estimate
-0.32
Earnings History > 10 > eps Difference
0.02
Earnings History > 10 > surprise Percent
6.25
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.37
Earnings History > 11 > eps Estimate
-0.32
Earnings History > 11 > eps Difference
-0.05
Earnings History > 11 > surprise Percent
-15.625
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.34
Earnings History > 12 > eps Estimate
-0.29
Earnings History > 12 > eps Difference
-0.05
Earnings History > 12 > surprise Percent
-17.2414
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.38
Earnings History > 13 > eps Estimate
-0.29
Earnings History > 13 > eps Difference
-0.09
Earnings History > 13 > surprise Percent
-31.0345
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.33
Earnings History > 14 > eps Estimate
-0.33
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-17
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.21
Earnings History > 15 > eps Estimate
-0.26
Earnings History > 15 > eps Difference
0.05
Earnings History > 15 > surprise Percent
19.2308
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.25
Earnings History > 16 > eps Estimate
-0.28
Earnings History > 16 > eps Difference
0.03
Earnings History > 16 > surprise Percent
10.7143
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-09-10
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.55
Earnings History > 17 > eps Estimate
-0.4
Earnings History > 17 > eps Difference
-0.15
Earnings History > 17 > surprise Percent
-37.5
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-02
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.82
Earnings History > 18 > eps Estimate
-0.82
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
0
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.8153
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.8153
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.14
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.14
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.6921
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.6921
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2019-12-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2019-12-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.5903
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.5903
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-09-30
Earnings History > 23 > report Date
2019-12-31
Earnings History > 23 > date
2019-09-30
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.4789
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.4789
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-06-30
Earnings History > 24 > report Date
2019-09-30
Earnings History > 24 > date
2019-06-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.4789
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
-0.4789
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-03-31
Earnings History > 25 > report Date
2019-06-30
Earnings History > 25 > date
2019-03-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.1618
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.1618
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2018-12-31
Earnings History > 26 > report Date
2019-03-31
Earnings History > 26 > date
2018-12-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.1618
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
-0.1618
Earnings History > 26 > surprise Percent
-
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALatent View Analytics Ltd : Indian Analytics For Data Of World - Stock Correlation Metrics & Consistent Triple Returns Bollywood Helpline
Read more →CEO Change: What risks investors should watch in GLRE stock - Market Growth Review & Fast Exit/Entry Strategy Plans moha.gov.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$46.9
Analyst Picks
Strong Buy
2
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 25.17% of the total shares of In8bio Inc
1.
BIOS CAPITAL MANAGEMENT, LP(6.3146%)
since
2025/03/31
2.
Franklin Resources Inc(4.1829%)
since
2025/06/30
3.
AIGH Capital Management, LLC(3.3019%)
since
2025/06/30
4.
Franklin Biotechnology Discv A(acc)USD(2.6477%)
since
2025/08/31
5.
Alyeska Investment Group, L.P.(1.8169%)
since
2025/06/30
6.
Stonepine Capital Management Llc(1.8158%)
since
2025/06/30
7.
Franklin Biotechnology Discovery A(1.5347%)
since
2025/07/31
8.
Vanguard Group Inc(1.3238%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(0.6844%)
since
2025/07/31
10.
Vanguard Institutional Extnd Mkt Idx Tr(0.429%)
since
2025/07/31
11.
Geode Capital Management, LLC(0.4146%)
since
2025/06/30
12.
Fidelity Extended Market Index(0.2318%)
since
2025/07/31
13.
Northwestern Mutual Wealth Management Co(0.0681%)
since
2025/06/30
14.
Fidelity Series Total Market Index(0.0572%)
since
2025/07/31
15.
Spartan Extended Market Index Pool F(0.0532%)
since
2025/07/31
16.
Northern Trust Extended Eq Market Idx(0.0465%)
since
2025/06/30
17.
NT Ext Equity Mkt Idx Fd - L(0.0465%)
since
2025/06/30
18.
Fidelity Total Market Index(0.0449%)
since
2025/07/31
19.
Tower Research Capital LLC(0.0334%)
since
2025/06/30
20.
Spartan Total Market Index Pool G(0.0225%)
since
2025/07/31
21.
NT Ext Equity Mkt Idx Fd - NL(0.0209%)
since
2025/06/30
22.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0162%)
since
2025/06/30
23.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0131%)
since
2025/06/30
24.
Fidelity Nasdaq Composite Index(0.0125%)
since
2025/07/31
25.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0111%)
since
2024/12/31
26.
UBS Group AG(0.0106%)
since
2025/06/30
27.
State St US Extended Mkt Indx NL Cl C(0.0096%)
since
2025/08/31
28.
BlackRock Inc(0.0019%)
since
2025/06/30
29.
Northern Trust Wilshire 5000(0.0011%)
since
2025/06/30
30.
Bank of America Corp(0.0005%)
since
2025/06/30
31.
Fidelity U.S. Equity Index Ins Trust(0.0001%)
since
2025/07/31
32.
Goldman Sachs Group Inc(0%)
since
2025/03/31
33.
683 Capital Management LLC(0%)
since
2025/03/31
34.
State Street Corp(0%)
since
2025/06/30
35.
Susquehanna International Group, LLP(0%)
since
2025/06/30
36.
Jane Street Group LLC(0%)
since
2025/03/31
37.
Northern Trust Corp(0%)
since
2025/06/30
38.
Sigma Planning Corp(0%)
since
2025/06/30
39.
Citadel Advisors Llc(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.85
EPS Estimate
-0.05
EPS Difference
-0.8
Surprise Percent
-1600%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.